Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00051103
Status:
COMPLETED
Last Update Posted:
2015-04-15
First Post:
2003-01-03
Brief Title:
Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin
Sponsor:
Organization:
GlaxoSmithKline